Sophia Randolph, M.D., Ph.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Sophia Randolph, M.D., Ph.D.
Earlier roles on record: Board Member at Alx Oncology Holdings Inc (ALXO) until August 5, 2024. Alx Oncology Holdings Inc reported in an 8-K filed October 4, 2024 that Sophia Randolph, M.D., Ph.D. resigned as Chief Medical Officer, effective October 11, 2024. Alx Oncology Holdings Inc reported in an 8-K filed August 6, 2024 that Sophia Randolph, M.D., Ph.D. resigned as member of the Company’s Board, effective August 5, 2024.
“On September 30, 2024, Sophia Randolph, M.D., Ph.D., Chief Medical Officer of ALX Oncology Holdings Inc. (the “Company”) informed the Company of her resignation from her position effective October 11, 2024, to pursue other professional opportunities.”
“In addition, on August 5, 2024, Jaume Pons, Ph.D., and Sophia Randolph, M.D., Ph.D., resigned as members of the Company’s Board.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2021-03-11–2024-08-05
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.